<DOC>
	<DOCNO>NCT00304252</DOCNO>
	<brief_summary>The purpose study determine safety efficacy interferon beta-1a maintain remission patient Crohn 's disease .</brief_summary>
	<brief_title>Safety Efficacy Treatment With Interferon Beta-1a RebifÂ® Patients With Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>Patients establish diagnosis Crohn 's disease go remission use corticosteroid within 4 week study Any treatment maintenance remission Crohn 's disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>